Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.37 EUR
−8.28 M EUR
55.34 M EUR
10.11 M
About BRAIN BIOTECH AG
Sector
Industry
CEO
Adriaan Moelker
Website
Headquarters
Zwingenberg
Founded
1993
ISIN
DE0005203947
FIGI
BBG00NRVY799
BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. It operates through the following segments: BioProducts, BioScience, and BioIncubator. The BioProducts segment consists of the product business with enzymes and other proteins. The BioScience segment offers research-intensive and customized solutions. The BioIncubator segment includes promising research and development projects with high value-added potential. The company was founded by Holger Zinke, Jüngen Eck, and Hans Günter Gassen on September 22, 1993 and is headquartered in Zwingenberg, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0RFI is 2.55 EUR — it has decreased by −3.41% in the past 24 hours. Watch BRAIN BIOTECH AG NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange BRAIN BIOTECH AG NPV stocks are traded under the ticker 0RFI.
0RFI stock has risen by 9.91% compared to the previous week, the month change is a −5.20% fall, over the last year BRAIN BIOTECH AG NPV has showed a −39.29% decrease.
We've gathered analysts' opinions on BRAIN BIOTECH AG NPV future price: according to them, 0RFI price has a max estimate of 15.00 EUR and a min estimate of 4.40 EUR. Watch 0RFI chart and read a more detailed BRAIN BIOTECH AG NPV stock forecast: see what analysts think of BRAIN BIOTECH AG NPV and suggest that you do with its stocks.
0RFI reached its all-time high on Apr 9, 2019 with the price of 11.70 EUR, and its all-time low was 1.47 EUR and was reached on Sep 13, 2024. View more price dynamics on 0RFI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0RFI stock is 8.64% volatile and has beta coefficient of 0.82. Track BRAIN BIOTECH AG NPV stock price on the chart and check out the list of the most volatile stocks — is BRAIN BIOTECH AG NPV there?
Today BRAIN BIOTECH AG NPV has the market capitalization of 57.68 M, it has decreased by −4.40% over the last week.
Yes, you can track BRAIN BIOTECH AG NPV financials in yearly and quarterly reports right on TradingView.
BRAIN BIOTECH AG NPV is going to release the next earnings report on Jan 15, 2025. Keep track of upcoming events with our Earnings Calendar.
0RFI net income for the last half-year is −4.56 M EUR, while the previous report showed −3.48 M EUR of net income which accounts for −31.05% change. Track more BRAIN BIOTECH AG NPV financial stats to get the full picture.
No, 0RFI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 309.00 employees. See our rating of the largest employees — is BRAIN BIOTECH AG NPV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BRAIN BIOTECH AG NPV EBITDA is −1.66 M EUR, and current EBITDA margin is −3.72%. See more stats in BRAIN BIOTECH AG NPV financial statements.
Like other stocks, 0RFI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRAIN BIOTECH AG NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRAIN BIOTECH AG NPV technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRAIN BIOTECH AG NPV stock shows the sell signal. See more of BRAIN BIOTECH AG NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.